TOP NEWS: AstraZeneca Leukaemia Study Meets Primary Endpoint
LONDON (Alliance News) - AstraZeneca PLC on Thursday reported positive results from its trial of Calquence in patients with chronic lymphocytic leukaemia, a type of blood cancer.The FTSE of Read More